Rahim, Hanan F. Abdul

SARS-CoV-2 reinfection in a cohort of 43,000 antibody-positive individuals followed for up to 35 weeks

Abu-Raddad, L. J., Chemaitelly, H., Coyle, P., Malek, J. A., Ahmed, A. A., Mohamoud, Y. A., Younuskunju, S., Ayoub, H. H., Kanaani, Z. A., Kuwari, E. A., et al. (2021) · EClinicalMedicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 201

Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic

Abu-Raddad, L. J., Chemaitelly, H., Ayoub, H. H., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Coyle, P., Jeremijenko, A., Kaleeckal, A. H., et al. (2021) · Scientific Reports

COVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 Research

Cited by 148

Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar

Jeremijenko, A., Chemaitelly, H., Ayoub, H. H., Alishaq, M., Abou-Samra, A.-B., Al Ajmi, J. A. A. A., Al Ansari, N. A. A., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., et al. (2021) · Emerging Infectious Diseases

COVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 Research

Cited by 97

Maternal and child health in the occupied Palestinian territory

Rahim, H. F. A., Wick, L., Halileh, S., Hassan-Bitar, S., Chekir, H., Watt, G., & Khawaja, M. (2009) · The Lancet

Global Maternal and Child HealthHealth and Conflict Studies

Cited by 92

Duration of protection of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 Omicron infection in Qatar

Chemaitelly, H., Ayoub, H. H., AlMukdad, S., Tang, P., Hasan, M. R., Yassine, H. M., Khatib, H. A. A., Smatti, M. K., Coyle, P., Kanaani, Z. A., et al. (2022) · medRxiv

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 30